Cell Genesys News

News on Cell Genesys (Ticker: CEGE) continually updated from thousands of sources around the net.

Feb 9, 2012 | Drugs.com

SEC Charges Former Pharmaceutical Company Employee with Insider Trading on Biotech Deals

WASHINGTON, Feb. 9, 2012 - The Securities and Exchange Commission today charged that a former employee of Takeda Pharmaceuticals International, Inc.

Comment?

Thu Nov 03, 2011

Business Journal

Pathwork Diagnostics names Sharon Tetlow as CFO

She was most recently senior vice president and CFO of Cell Genesys, a publicly traded biotechnology company which was acquired by BioSante .

Comment?

Mon Mar 22, 2010

East Bay Business Times

Icahn, Biogen agree to end proxy battle

BIO chairman and former Cell Genesys boss Dr. Stephen Sherwin is at the center of a resolution of the proxy fight between Biogen Idec and dissident shareholder Carl Icahn.

Comment?

Wed Feb 03, 2010

East Bay Business Times

Nektar adds to board of directors

Nektar Therapeutics Inc. added Scott Greer of Numenor Ventures LLC to its board of directors.

Comment?

Thu Oct 29, 2009

Freshnews

BioSante Pharmaceuticals to Present at the Oppenheimer Health Care Conference

BioSante Pharmaceuticals, Inc. today announced that Stephen M. Simes, its president and CEO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel update at the Oppenheimer 20th Annual Healthcare Conference to be held on November 3-4, 2009 at the Waldorf-Astoria in New York City.

Comment?